The Southern Society for Clinical Investigation logo for print

1824 Sixth Avenue South, WTI 205
Birmingham, AL 35294-3300


Phone: 205-934-5077
Fax: 205-975-7428

Contact Us
shadow

Patrice Delafontaine, MD

Patrice Delafontaine, MD

University of Missouri Health Science Center
One Hospital Drive, DC018.00

Columbia, MO 65212

Columbia, MO 65212

Phone: (573) 884-9080
delafontainep@health.missouri.edu

Assistant: Patricia Barrows
Phone: (504) 988-2025
pbarro@tulane.edu

Member Since: 2005


Title

interventional cardiologist, Medical Dir., Cardiovascular Services

Specialty/Subspecialty

Cardiology

Clinical Interest(s)

Interventional Cardiology, Vascular Biology, Physician-Scientist

Research Interest(s)

  • growth factors
  • cellular and molecular biology
  • atherosclerosis

Current / Former SSCI Roles

About Patrice Delafontaine, MD

Dr. Delafontaine is currently Professor of Medicine and of Medical Pharmacology and Physiology at the University of Missouri - Columbia School of Medicine. He completed his studies and received his Doctorate in Medicine at the University of Geneva in Geneva, Switzerland, and his residency in Internal Medicine at the Hahnemann Medical College and Hospital in Philadelphia, PA. He completed a research and a clinical fellowship program in cardiology at Harvard Medical School and Brigham and Women's Hospital in Boston, Massachusetts.

Dr. Delafontaine has held positions at Emory University, the University of Geneva, the University of Kansas Medical School, and Tulane University. During his tenure at Tulane he was the Vice Chair of Research for the Department of Medicine, Chief of the Section of Cardiology, Director of the Tulane Heart and Vascular Institute, and was the Interim Chair of the Department of Medicine. He was also the Director of the NIH funded Louisiana Clinical and Translational Science Center's Clinical Translational Unit at the Tulane University. In December 2014, Dr. Delafontaine was appointed as the Hugh E. and Sarah D. Stephenson Dean at the University of Missouri - Columbia.

Dr. Delafontaine's research has been continuously funded for over 20 years by the NIH. Current areas of investigative focus include 1) the Role of IGF I and its Binding Proteins in Vascular Growth and Atherosclerosis; 2) Vascular Smooth Muscle and Endothelial Cell Biology; 3) Unstable Angina and Coronary Atherosclerosis; and 4) Mechanisms of Muscle Wasting in Chronic Disease States.

Dr. Delafontaine has been a member of the Southern Society for Clinical Investigation since 2005, and has served on the Council and Nominating committee. He currently serves on the Mentoring committee and the Speakers Bureau of the Visiting Professor Program of the SSCI.

ruler

The SSCI Thanks Its Sponsors

  • Elsevier sponsors The Southern Society for Clinical Investigation
  •  
  • AstraZeneca sponsors The Southern Society for Clinical Investigation